ATOS•benzinga•
Atossa Therapeutics FY 2024 GAAP EPS $(0.20) Beats $(0.22) Estimate, Cash $71.1M
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 25, 2025 by benzinga